Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
S-8
Registration of securities for employees
17 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
424B5
Prospectus supplement for primary offering
20 Mar 24
8-K
Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
20 Mar 24
8-K
Other Events
6 Mar 24
8-K
Other Events
26 Feb 24
8-K
Departure of Directors or Certain Officers
5 Feb 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Material Modifications to Rights of Security Holders
31 Jan 24
8-K
Regulation FD Disclosure
5 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
18 Dec 23
424B5
Prospectus supplement for primary offering
13 Dec 23
8-K
Entry into a Material Definitive Agreement
13 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
DEFA14A
Additional proxy soliciting materials
3 Nov 23
DEF 14A
Definitive proxy
3 Nov 23
PRE 14A
Preliminary proxy
23 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
23 Oct 23
8-K
Changes in Registrant's Certifying Accountant
25 Sep 23
8-K
Regulation FD Disclosure
8 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Sep 23
8-K/A
Changes in Registrant's Certifying Accountant
21 Aug 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
424B5
Prospectus supplement for primary offering
20 Jul 23
8-K
Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19 Jul 23
8-K
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
18 Jul 23
8-K
Changes in Registrant's Certifying Accountant
14 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
27 Jun 23
EFFECT
Notice of effectiveness
12 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
8-K
Other Events
26 May 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
8-K/A
Changes in Registrant's Certifying Accountant
12 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
Latest ownership filings
4
Mark Stanley Berger
21 Feb 24
4
John Rodney Varner
21 Feb 24
4
Ryan M. Confer
21 Feb 24
SC 13G/A
CVI Investments, Inc.
14 Feb 24
SC 13G
CVI Investments, Inc.
24 Jul 23
4
Toscano Jose Antonio Moreno
29 Jun 23
4
BRENT M LONGNECKER
29 Jun 23
4
William R Jr. Wilson
29 Jun 23
4
John Rodney Varner
24 Apr 23
4
CATHERINE M VACZY
24 Apr 23
4
CATHERINE M VACZY
22 Feb 23
4
Mark Stanley Berger
22 Feb 23
4
Hermant Kumar
22 Feb 23
4
Ryan M. Confer
22 Feb 23
4
John Rodney Varner
22 Feb 23
4
Ryan M. Confer
1 Aug 22
3/A
Ryan M. Confer
29 Jul 22
4
Toscano Jose Antonio Moreno
27 Jun 22
4
BRENT M LONGNECKER
27 Jun 22
4
William R Jr. Wilson
27 Jun 22
4
Hermant Kumar
27 Jun 22
5
John Rodney Varner
14 Feb 22
4
CATHERINE M VACZY
8 Feb 22
4
Ryan M. Confer
8 Feb 22
4
John Rodney Varner
8 Feb 22
4
Mark Stanley Berger
8 Feb 22
4
Hermant Kumar
8 Feb 22
4
Hermant Kumar
28 Sep 21
4
Mark Stanley Berger
28 Sep 21
3
Hermant Kumar
28 Sep 21
3
Mark Stanley Berger
28 Sep 21
4
William R Jr. Wilson
25 Jun 21
4
Toscano Jose Antonio Moreno
25 Jun 21
4
BRENT M LONGNECKER
25 Jun 21
4
BRENT M LONGNECKER
7 Apr 21
3/A
BRENT M LONGNECKER
7 Apr 21
4
Ryan M. Confer
23 Mar 21
4
CATHERINE M VACZY
23 Mar 21
4
John Rodney Varner
23 Mar 21
4
Michael Thomas Redman
23 Mar 21